[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100644641":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":13,"locations":19,"responsibleParty":37,"collaborators":41,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":10,"maxAge":10,"enrollmentInfo":53,"targetDuration":56,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":63,"overallStatus":68,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Salzburger Landeskliniken","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"Patients",null,{"label":12,"type":10,"description":10,"interventionNames":10},"Controls",[14],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":18},"Lorenz Stana-Hackenberg, MD","CONTACT","+4357255-57757","L.stana-hackenberg@salk.at",[20],{"facility":21,"status":10,"city":22,"state":10,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Wroclaw Medical University","Wroclaw","50367","Poland","PL",{"type":27,"coordinates":28},"Point",[29,30],17.03006,51.10286,{"lat":30,"lon":29},[33],{"name":34,"role":16,"phone":35,"phoneExt":10,"email":36},"Barbara Królak-Olejnik, Prof.","+48 71 7331500","kne@usk.wroc.pl",{"type":38,"investigatorFullName":39,"investigatorTitle":40,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Lorenz Auer-Hackenberg","Principal Investigator",[42,43],{"name":21,"class":6},{"name":44,"class":6},"Ludwig Boltzmann Gesellschaft","100644641","t6a-biomarker-for-detection-of-bacterial-infection-in-newborn-infants-100644641",false,"NCT07670624","T6A Biomarker for Detection of Bacterial Infection in Newborn Infants","T6ASepsis","Inclusion Criteria:\n\n* Newborn infants who require blood testing for screening for bacterial infection OR treating physician suspects bacterial infection in newborn infant\n* Signed informed consent form\n\nExclusion Criteria:\n\n1. Refusal to participate in study or not providing written informed consent by caregivers\u002Fparents\n2. Antibiotic treatment of any kind.","ALL",{"count":54,"type":55},210,"ESTIMATED","1 Week","OBSERVATIONAL","This study aims to assess the efficacy of a new biomarker, N6-threonylcarbamoyladenosine (t6A), for the early diagnosis of Early-Onset Sepsis (EOS) in newborns.",[60,61,62],"Sepsis","Newborn Sepsis","Biomarker Discovery",[64,65,66,67],"t6a","newborn sepsis","infectious disease biomarker","biomarker","NOT_YET_RECRUITING","2026-08-13",{"date":71,"type":72},"2026-08-17","ACTUAL",{"date":74,"type":55},"2026-09-01",{"date":76,"type":55},"2029-01-31",{"name":5,"class":6},1]